Stockreport

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF integrated biotechnology company developing therapies and vaccines to bolster the natural immune system for cancers and infectious diseases. In April this year, the FD [Read more]